CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Ordinary shares	Additional paid-in capital	Additional paid-in capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated other comprehensive loss	Retained earnings (accumulated deficit)	Retained earnings (accumulated deficit) Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2020			102,334,276
Beginning balance at Dec. 31, 2020	$ 476,526	$ (128,972)		$ 1,111,435	$ (132,474)	$ (3,832)	$ (631,077)	$ 3,502
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation to employees	18,863			18,863
Exercise of options and vested RSUs (in shares)			853,184
Exercise of options and vested RSUs	$ 7,961			7,961
Accounting standards update [extensible enumeration]	Accounting Standards Update 2020-06 [Member]
Other comprehensive income (loss), net of tax benefit	$ 1,884					1,884
Net income (loss)	(4,128)						(4,128)
Ending balance (in shares) at Mar. 31, 2021			103,187,460
Ending balance at Mar. 31, 2021	372,134			1,005,785		(1,948)	(631,703)
Beginning balance (in shares) at Dec. 31, 2020			102,334,276
Beginning balance at Dec. 31, 2020	476,526	(128,972)		1,111,435	(132,474)	(3,832)	(631,077)	3,502
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(31,893)
Ending balance (in shares) at Sep. 30, 2021			103,817,566
Ending balance at Sep. 30, 2021	413,164			1,073,532		(900)	(659,468)
Beginning balance (in shares) at Dec. 31, 2020			102,334,276
Beginning balance at Dec. 31, 2020	476,526	$ (128,972)		1,111,435	$ (132,474)	(3,832)	(631,077)	$ 3,502
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(58,351)
Ending balance (in shares) at Dec. 31, 2021			103,971,263
Ending balance at Dec. 31, 2021	410,494			1,099,589		(3,169)	(685,926)
Beginning balance (in shares) at Mar. 31, 2021			103,187,460
Beginning balance at Mar. 31, 2021	372,134			1,005,785		(1,948)	(631,703)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation to employees	27,881			27,881
Proceeds from issuance of shares (in shares)			17,291
Proceeds from issuance of shares	2,371			2,371
Exercise of options and warrants and vested RSUs (in shares)			436,487
Exercise of options and vested RSUs	8,695			8,695
Other comprehensive income (loss), net of tax benefit	829					829
Net income (loss)	(14,641)						(14,641)
Ending balance (in shares) at Jun. 30, 2021			103,641,238
Ending balance at Jun. 30, 2021	397,269			1,044,732		(1,119)	(646,344)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation to employees	25,758			25,758
Exercise of options and warrants and vested RSUs (in shares)			176,328
Exercise of options and vested RSUs	3,042			3,042
Other comprehensive income (loss), net of tax benefit	219					219
Net income (loss)	(13,124)						(13,124)
Ending balance (in shares) at Sep. 30, 2021			103,817,566
Ending balance at Sep. 30, 2021	413,164			1,073,532		(900)	(659,468)
Beginning balance (in shares) at Dec. 31, 2021			103,971,263
Beginning balance at Dec. 31, 2021	410,494			1,099,589		(3,169)	(685,926)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation to employees	25,045			25,045
Exercise of options and vested RSUs (in shares)			587,825
Exercise of options and vested RSUs	3,148			3,148
Other comprehensive income (loss), net of tax benefit	1,841					1,841
Net income (loss)	(4,647)						(4,647)
Ending balance (in shares) at Mar. 31, 2022			104,559,088
Ending balance at Mar. 31, 2022	435,881			1,127,782		(1,328)	(690,573)
Beginning balance (in shares) at Dec. 31, 2021			103,971,263
Beginning balance at Dec. 31, 2021	410,494			1,099,589		(3,169)	(685,926)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(55,231)
Ending balance (in shares) at Sep. 30, 2022			104,942,941
Ending balance at Sep. 30, 2022	445,401			1,188,864		(2,306)	(741,157)
Beginning balance (in shares) at Mar. 31, 2022			104,559,088
Beginning balance at Mar. 31, 2022	435,881			1,127,782		(1,328)	(690,573)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation to employees	25,823			25,823
Exercise of options and vested RSUs (in shares)			121,888
Exercise of options and vested RSUs	1,984			1,984
Proceeds from issuance of shares (in shares)			46,709
Proceeds from issuance of shares	2,759			2,759
Other comprehensive income (loss), net of tax benefit	(767)					(767)
Net income (loss)	(24,008)						(24,008)
Ending balance (in shares) at Jun. 30, 2022			104,727,685
Ending balance at Jun. 30, 2022	441,672			1,158,348		(2,095)	(714,581)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation to employees	26,305			26,305
Exercise of options and vested RSUs (in shares)			215,256
Exercise of options and vested RSUs	4,211			4,211
Other comprehensive income (loss), net of tax benefit	(211)					(211)
Net income (loss)	(26,576)						(26,576)
Ending balance (in shares) at Sep. 30, 2022			104,942,941
Ending balance at Sep. 30, 2022	$ 445,401			$ 1,188,864		$ (2,306)	$ (741,157)